Atlas Trials

to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers

Clinical trial NCT04593511 · UNKNOWN

Trial details

NCT number
NCT04593511
Sponsor
Luye Pharma Group Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2021-02-02
Primary completion
2021-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.